This Editas Medicine Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
benzinga_article·- Stifel upgraded Microsoft Corp to Buy with a price target of $575. - JP Morgan upgraded Graphic Packaging Holding Co to Overweight, and Guggenheim upgraded Editas Medicine Inc to Buy with a $5 target. - RBC Capital upgraded Lakefront Biotherapeutics NV to Outperform and raised its price target to $45.